Current and historical daily PE Ratio for Beijing Northland Biotech Co Ltd (
BJSE:430047
) from 2020 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Northland Biotech stock (BJSE:430047) PE ratio as of Jun 18 2024 is 0.
More Details
Beijing Northland Biotech Co Ltd (BJSE:430047) PE Ratio (TTM) Chart
Beijing Northland Biotech Co Ltd (BJSE:430047) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 1212
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Beijing Northland Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-18 | At Loss | 2024-04-15 | At Loss |
| 2024-06-18 | At Loss | 2024-04-12 | At Loss |
| 2024-06-17 | At Loss | 2024-04-11 | At Loss |
| 2024-06-14 | At Loss | 2024-04-10 | At Loss |
| 2024-06-13 | At Loss | 2024-04-09 | At Loss |
| 2024-06-12 | At Loss | 2024-04-08 | At Loss |
| 2024-06-11 | At Loss | 2024-04-05 | At Loss |
| 2024-06-07 | At Loss | 2024-04-03 | At Loss |
| 2024-06-06 | At Loss | 2024-04-02 | At Loss |
| 2024-06-05 | At Loss | 2024-04-01 | At Loss |
| 2024-06-04 | At Loss | 2024-03-29 | At Loss |
| 2024-06-03 | At Loss | 2024-03-28 | At Loss |
| 2024-05-31 | At Loss | 2024-03-27 | At Loss |
| 2024-05-30 | At Loss | 2024-03-26 | At Loss |
| 2024-05-29 | At Loss | 2024-03-25 | At Loss |
| 2024-05-28 | At Loss | 2024-03-22 | At Loss |
| 2024-05-27 | At Loss | 2024-03-21 | At Loss |
| 2024-05-24 | At Loss | 2024-03-20 | At Loss |
| 2024-05-23 | At Loss | 2024-03-19 | At Loss |
| 2024-05-22 | At Loss | 2024-03-18 | At Loss |
| 2024-05-21 | At Loss | 2024-03-15 | At Loss |
| 2024-05-20 | At Loss | 2024-03-14 | At Loss |
| 2024-05-17 | At Loss | 2024-03-13 | At Loss |
| 2024-05-16 | At Loss | 2024-03-12 | At Loss |
| 2024-05-15 | At Loss | 2024-03-11 | At Loss |
| 2024-05-14 | At Loss | 2024-03-08 | At Loss |
| 2024-05-13 | At Loss | 2024-03-07 | At Loss |
| 2024-05-10 | At Loss | 2024-03-06 | At Loss |
| 2024-05-09 | At Loss | 2024-03-05 | At Loss |
| 2024-05-08 | At Loss | 2024-03-04 | At Loss |
| 2024-05-07 | At Loss | 2024-03-01 | At Loss |
| 2024-05-06 | At Loss | 2024-02-29 | At Loss |
| 2024-05-03 | At Loss | 2024-02-28 | At Loss |
| 2024-05-02 | At Loss | 2024-02-27 | At Loss |
| 2024-04-30 | At Loss | 2024-02-26 | At Loss |
| 2024-04-29 | At Loss | 2024-02-23 | At Loss |
| 2024-04-26 | At Loss | 2024-02-22 | At Loss |
| 2024-04-25 | At Loss | 2024-02-21 | At Loss |
| 2024-04-24 | At Loss | 2024-02-20 | At Loss |
| 2024-04-23 | At Loss | 2024-02-19 | At Loss |
| 2024-04-22 | At Loss | 2024-02-16 | At Loss |
| 2024-04-19 | At Loss | 2024-02-09 | At Loss |
| 2024-04-18 | At Loss | 2024-02-08 | At Loss |
| 2024-04-17 | At Loss | 2024-02-07 | At Loss |
| 2024-04-16 | At Loss | 2024-02-06 | At Loss |
Beijing Northland Biotech Co Ltd (BJSE:430047) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Beijing Northland Biotech Co Ltd
ISIN : CNE1000044K7
Compare
Compare
Traded in other countries / regions
430047.China IPO Date
2020-11-24Description
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers